Gabriella Magarelli
Acute Care · Hackensack, NJNPI 1093042145
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Genmab U.S., Inc. accounts for 73.9% of it on its own, with 22 other manufacturers making up the rest. Among acute care clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $420.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genmab U.S., Inc.$32K
- AbbVie$10K
- Epizyme, Inc.$438
- Sanofi$261
- Amgen$126
- Merck$118
- plus $809 from 17 others
What the payments were for
- Consulting fees$12,06328%
- Speaking & faculty fees$25,85259%
- Travel & lodging$2,6376%
- Food & beverage$3,0837%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genmab U.S., Inc. | 39 | $32,339 |
| AbbVie | 21 | $9,644 |
| Epizyme, Inc. | 1 | $438 |
| Sanofi | 3 | $261 |
| Amgen | 2 | $126 |
| Merck | 4 | $118 |
| Exelixis Inc. | 1 | $103 |
| Gilead | 1 | $100 |
| Tolmar, Inc. | 5 | $90 |
| Taiho Oncology, Inc. | 4 | $79 |
| Pharmaand GmbH | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
| AstraZeneca(2 entities) | 3 | $66 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $43 |
| Novartis | 2 | $38 |
| Tempus AI, Inc | 1 | $29 |
| Eisai Inc. | 1 | $26 |
| Beone Medicines USA, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Morphosys, US Inc. | 1 | $14 |
| Karyopharm Therapeutics Inc. | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$43,734 in reported general payments places this provider in the 95th percentile of 656 acute care providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 30 | $899 |
| Acyclovir | 22 | $274 |
| Dexamethasone | 14 | $106 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 40 | $86 |
| Allopurinol | 12 | $45 |
| Prednisone | 20 | $42 |
Paid to pharmacies, not to this prescriber.
Other acute care in Hackensack
- Maria Tedi CoronelHackensack$19K
- Patricia WaltersHackensack$10K
- Pamela Rose-DeandreaHackensack$3K
- Per RosenkvistLivingston$29K
- Matthew OstroffPaterson$27K
- Ellen McCueNeptune$26K
- Suzanne ShuggLivingston$25K
- Hanane ChaibainouWestampton$16K
- Jennifer McCarthyNewark$16K
- Jennifer HarrarCamden$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.